Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK R...

por Giovannoni, G, Brex, PA, Dhiraj, D, Fullarton, J, Freddi, M, Rodgers-Gray, B, Schmierer, K
Publicado 2019